Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NPI 1275697435
NPI deactivated

1275697435

1275697435 was paid $4.43M by Medicaid between Jan 2018 and Oct 2020, across 17 billing codes. Its largest line is J7605, Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms — 46% of everything it billed.

33Billing provider info1275697435
33aNPI1275697435
33bProvider type—
28Total paid$4.43M
24GClaims410,397
24DCodes billed17
24AFirst – last monthJan 2018 – Oct 2020
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018272,237$2.91M
2019132,771$1.51M
20205,389$1K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J7605 Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms 46% 31,800 27,108 $2.04M
J7606 Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms 20% 11,350 9,809 $871K
J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg 10% 37,722 32,356 $453K
Q0513 Pharmacy dispensing fee for inhalation drug(s); per 30 days 9.6% 154,756 134,232 $423K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 6.9% 72,574 62,063 $305K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 6.2% 81,326 69,928 $275K
G0333 Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary <1% 5,479 4,945 $34K
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 12,896 11,034 $20K
J7677 Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram <1% 371 60 $5K
J7699 Noc drugs, inhalation solution administered through dme <1% 21 19 $2K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 102 90 $1K
E1390 Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate <1% 43 43 $703.58
5 more codes
A7005 Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable <1% 270 $3.13
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable <1% 822 $1.22
A7015 Aerosol mask, used with dme nebulizer 0% 365 $0.00
E0570 Nebulizer, with compressor 0% 459 $0.00
A7013 Filter, disposable, used with aerosol compressor or ultrasonic generator 0% 41 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.